Literature DB >> 15177778

Bio-markers of disease activity and response to therapy in multiple sclerosis.

Ariel Miller1, Lea Glass-Marmor, Michal Abraham, Iris Grossman, Sarah Shapiro, Yanina Galboiz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15177778     DOI： 10.1016/j.clineuro.2004.02.008

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  8 in total

1.  Plasma homocysteine levels in multiple sclerosis.

Authors:  G S M Ramsaransing; M R Fokkema; A Teelken; A V Arutjunyan; M Koch; J De Keyser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

2.  Serum uric acid levels and neuromyelitis optica.

Authors:  Fuhua Peng; Xiufeng Zhong; Xuhui Deng; Wei Qiu; Aimin Wu; Youming Long; Xueqiang Hu; Qing Li; Ying Jiang; Yongqiang Dai
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

3.  Biomarkers in chronic adult hydrocephalus.

Authors:  Andrew Tarnaris; Laurence D Watkins; Neil D Kitchen
Journal:  Cerebrospinal Fluid Res       Date:  2006-10-04

Review 4.  Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.

Authors:  Genaro G Ortiz; Fermín P Pacheco-Moisés; Oscar K Bitzer-Quintero; Ana C Ramírez-Anguiano; Luis J Flores-Alvarado; Viridiana Ramírez-Ramírez; Miguel A Macias-Islas; Erandis D Torres-Sánchez
Journal:  Clin Dev Immunol       Date:  2013-09-24

5.  Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: glial proteins associated with cell damage and loss.

Authors:  Irum Naureen; Khawaja A Irfan Waheed; Ahsen W Rathore; Suresh Victor; Conor Mallucci; John R Goodden; Shahid N Chohan; Jaleel A Miyan
Journal:  Fluids Barriers CNS       Date:  2013-12-18

6.  CSF levels of myelin basic protein in pediatric patients with ventriculoperitoneal shunt infection.

Authors:  Bartosz Polis; Lech Polis; Krzysztof Zeman; Jarosław Paśnik; Emilia Nowosławska
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

7.  TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.

Authors:  Celia Oreja-Guevara; Jaime Ramos-Cejudo; Luiz Stark Aroeira; Beatriz Chamorro; Exuperio Diez-Tejedor
Journal:  BMC Neurol       Date:  2012-09-18       Impact factor: 2.474

8.  Serum uric acid levels in patients with myasthenia gravis are inversely correlated with disability.

Authors:  Dehao Yang; Yiyun Weng; Haihua Lin; Feiyan Xie; Fang Yin; Kangliang Lou; Xuan Zhou; Yixiang Han; Xiang Li; Xu Zhang
Journal:  Neuroreport       Date:  2016-03-23       Impact factor: 1.837
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.